This case study shows how farmers can achieve significant energy savings and a swift return on investment with proper ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company" or "Plus Therapeutics"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics ...

Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® technology IMNN-101 induced 2- to 4-fold increase in neutralizing ...

A single regulator for construction is among a raft of measures announced today (26 February) in response to the Grenfell ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company” or "Plus Therapeutics”), a clinical-stage pharmaceutical company ...

We think it can be appropriate to present phase 2 trial participation as offering a small prospect of benefit,” researchers wrote. About 16% of patients enrolled in phase 2 cancer trials receive a ...

Good morning, and welcome to Tarsus Year End 2024 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the call over to David Nakasone, ...

Monroe Biomedical Research (MBR), a dedicated clinical trial site, is growing its footprint to enhance early-phase clinical ...

More than 850,000 farms and ranches nationwide have a lower tax bill under the Section 199A qualified business income ...

Kiniksa plans to initiate a Phase 2/3 clinical trial of KPL-387 in recurrent pericarditis in mid-2025 –– KPL-387 Phase 1 single ascending dose ...

Belle Farm s first phase begins in Middleton, featuring 150 eco friendly homes with geothermal energy, solar power, and a ...

Following a public hearing Tuesday, the Weber County Commission officially approved proposed rezoning for Phase 6 of the ...